Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data

Hsin Fen Chien; Ana Lucia Zuma de Rosso; André Sobierajski dos Santos; Carlos Roberto de Mello Rieder; Debora Palma Maia; Delson José da Silva; Marcio da Cunha Andrade; Marcus Vinicius Della Coletta; Maria do Desterro Leiros da Costa; Nasser Allam; Roberto César Pereira do Prado; Vanderci Borges; Vitor Tumas; Wagner de Goes Horta

eNeurologicalSci (Dec 2016)

Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data

Hsin Fen Chien,
Ana Lucia Zuma de Rosso,
André Sobierajski dos Santos,
Carlos Roberto de Mello Rieder,
Debora Palma Maia,
Delson José da Silva,
Marcio da Cunha Andrade,
Marcus Vinicius Della Coletta,
Maria do Desterro Leiros da Costa,
Nasser Allam,
Roberto César Pereira do Prado,
Vanderci Borges,
Vitor Tumas,
Wagner de Goes Horta

Affiliations

Hsin Fen Chien: University of São Paulo School of Medicine, Brazil; Corresponding author.
Ana Lucia Zuma de Rosso: Department of Movement Disorders of the Neurology, Service Prof. Sérgio Novis, HUCFF/UFRJ, Brazil
André Sobierajski dos Santos: Universidade do Sul de Santa Catarina (UNISUL), Movement Disorders Outpatient Clinic of the Santa Catarina Rehabilitation Center, Brazil
Carlos Roberto de Mello Rieder: Universidade Federal Ciências da Saúde de Porto Alegre (UCSPA), Universidade Federal do Rio Grande do Sul, Brazil
Debora Palma Maia: Movement Disorders Outpatient Clinic of HC/UFMG, Medical School of the PUC Minas, Brazil
Delson José da Silva: The Neurology and Neurosurgery Unit of HC-UFG/EBSERH, IINEURO - Integrated Institute for Neuroscience, Brazil
Marcio da Cunha Andrade: Neurology Department of the Hospital das Clinicas, Federal University of Pernambuco, Brazil
Marcus Vinicius Della Coletta: Amazonas State University, Brazil
Maria do Desterro Leiros da Costa: Federal University of Paraíba, Brazil
Nasser Allam: Universidade de Brasília – UnB, Brazil
Roberto César Pereira do Prado: Federal University of Sergipe/UFS, Parkinson's Clinic and the UH Movement Disorders/UFS, Brazil
Vanderci Borges: Department of Neurology and Neurosurgery, UNIFESP, Brazil
Vitor Tumas: Ribeirão Preto Medical School, University of São Paulo, Brazil
Wagner de Goes Horta: Federal University of Ceará, Brazil

Journal volume & issue: Vol. 5
pp. 11 – 14

Abstract

Read online

Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). Analyzing the Datasus data (Unified Health System Information Department of Brazilian Ministry of Health), it was noticed that in Brazil the percentage of dystonic patient benefited from this procedure is still low. We therefore suggest some strategies to increase the dispensation of the toxin by the Brazilian Unified Health system for the dystonic patients. Keywords: Botulinum toxin, Dystonia, Facial spasm, Blepharospasm

Published in eNeurologicalSci

ISSN: 2405-6502 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
Website: https://www.journals.elsevier.com/eneurologicalsci/

About the journal